Our uterine leiomyosarcoma nomogram is a prediction tool designed to help patients and their physicians calculate the likely outcome of their surgical treatment for uterine leiomyosarcoma, a type of uterine cancer. It is not appropriate for patients who have not had surgery to remove their uterine leiomyosarcoma.
All results from this tool should be discussed with a physician and understood in the context of each patient’s program of care. Results from the uterine leiomyosarcoma nomogram are based on data from patients treated at MSK, a large research institution with surgeons who perform a high volume of uterine cancer procedures. This tool has been externally validated using data from patients treated at large, international sarcoma centers (see Supporting Publications).
Use our Uterine Leiomyosarcoma: Overall Survival Probability Following Surgery nomogram.